8.4 Pediatric Use Acquired HO The safety and effectiveness of IMCIVREE have been established to reduce excess body weight and maintain weight reduction long term in pediatric patients aged 4 years and older with acquired HO
Published research has explored its role in promoting angiogenesis (new blood vessel formation), upregulating VEGF (vascular endothelial growth factor), stimulating fibroblast migration and collagen deposition, modulating nitric oxide pathways, and protecting the gastrointestinal lining
Our skilled medical professionals will administer the MICC injections directly into a muscle site during your treatment, with injection sites including the buttocks, thigh, hip, or upper arm
The bodys natural hunger hormones can work against you, making it hard to feel full, regulate blood sugar, and maintain a healthy weight over time